These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36443822)

  • 1. Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-β inhibition.
    Mancarella S; Gigante I; Serino G; Pizzuto E; Dituri F; Valentini MF; Wang J; Chen X; Armentano R; Calvisi DF; Giannelli G
    J Exp Clin Cancer Res; 2022 Nov; 41(1):331. PubMed ID: 36443822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis.
    Mancarella S; Serino G; Dituri F; Cigliano A; Ribback S; Wang J; Chen X; Calvisi DF; Giannelli G
    Cell Death Differ; 2020 Aug; 27(8):2330-2343. PubMed ID: 32042099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tumor Microenvironment Drives Intrahepatic Cholangiocarcinoma Progression.
    Mancarella S; Serino G; Coletta S; Armentano R; Dituri F; Ardito F; Ruzzenente A; Fabregat I; Giannelli G
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cancer-associated fibroblasts/tumor cells cross-talk inhibits intrahepatic cholangiocarcinoma progression via cell-cycle arrest.
    Mancarella S; Gigante I; Pizzuto E; Serino G; Terzi A; Dituri F; Maiorano E; Vincenti L; De Bellis M; Ardito F; Calvisi DF; Giannelli G
    J Exp Clin Cancer Res; 2024 Oct; 43(1):286. PubMed ID: 39415286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs.
    Yang R; Wang D; Han S; Gu Y; Li Z; Deng L; Yin A; Gao Y; Li X; Yu Y; Wang X
    Int J Biol Sci; 2022; 18(1):43-64. PubMed ID: 34975317
    [No Abstract]   [Full Text] [Related]  

  • 6. CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype.
    Mancarella S; Serino G; Gigante I; Cigliano A; Ribback S; Sanese P; Grossi V; Simone C; Armentano R; Evert M; Calvisi DF; Giannelli G
    J Exp Clin Cancer Res; 2022 Feb; 41(1):65. PubMed ID: 35172861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
    Ravichandra A; Bhattacharjee S; Affò S
    Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin receptor blockers retard the progression and fibrosis via inhibiting the viability of
    Li JH; Wu X; Ni X; Li YX; Xu L; Hao XY; Zhao W; Zhu XX; Yin XY
    Clin Transl Med; 2023 Mar; 13(3):e1213. PubMed ID: 36855786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zerumbone, a humulane sesquiterpene from Syringa pinnatifolia, attenuates cardiac fibrosis by inhibiting of the TGF-β1/Smad signaling pathway after myocardial infarction in mice.
    Li J; Ge F; Wuken S; Jiao S; Chen P; Huang M; Gao X; Liu J; Tu P; Chai X; Huang L
    Phytomedicine; 2022 Jun; 100():154078. PubMed ID: 35405613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory Effect of Corilagin on miR-21-Regulated Hepatic Fibrosis Signaling Pathway.
    Zhou X; Xiong J; Lu S; Luo L; Chen ZL; Yang F; Jin F; Wang Y; Ma Q; Luo YY; Wang YJ; Zhou JB; Liu P; Zhao L
    Am J Chin Med; 2019; 47(7):1541-1569. PubMed ID: 31752524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine-specific demethylase 1 induced epithelial-mesenchymal transition and promoted renal fibrosis through Jagged-1/Notch signaling pathway.
    Zhang H; Xing J; Zhao L
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S203-S214. PubMed ID: 34396798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of transforming growth factor -β1 on α-smooth muscle actin and collagen expression in equine endometrial fibroblasts.
    Szóstek-Mioduchowska AZ; Lukasik K; Skarzynski DJ; Okuda K
    Theriogenology; 2019 Jan; 124():9-17. PubMed ID: 30321755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matricellular proteins in intrahepatic cholangiocarcinoma.
    Sirica AE
    Adv Cancer Res; 2022; 156():249-281. PubMed ID: 35961702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
    Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
    J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor-Stroma Paracrine Signaling.
    Lobe C; Vallette M; Arbelaiz A; Gonzalez-Sanchez E; Izquierdo L; Pellat A; Guedj N; Louis C; Paradis V; Banales JM; Coulouarn C; Housset C; Vaquero J; Fouassier L
    Hepatology; 2021 Dec; 74(6):3194-3212. PubMed ID: 34297412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
    Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
    Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
    Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
    Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Geniposide inhibits hepatic fibrosis and hepatic stellate cell activation through blocking the TGF-β1/Smad signaling pathway].
    Zhou LH; Chen X
    Sheng Li Xue Bao; 2022 Apr; 74(2):217-224. PubMed ID: 35503069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
    Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
    Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.